Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 6/2011

01-12-2011 | Original Article

Classification of acute encephalopathy in respiratory syncytial virus infection

Authors: Shinichiro Morichi, Hisashi Kawashima, Hiroaki Ioi, Gaku Yamanaka, Yasuyo Kashiwagi, Akinori Hoshika, Tetsuo Nakayama, Yasuo Watanabe

Published in: Journal of Infection and Chemotherapy | Issue 6/2011

Login to get access

Abstract

Infection with respiratory syncytial virus (RSV) is known to be associated with central nervous system symptoms such as convulsions. We investigated cytokines, nitrogen oxide (NO) x , and the viral genome in cerebrospinal fluid (CSF) obtained from children with RSV infection-related convulsions or central nervous symptoms and compared the data with type of encephalopathy. Of nine patients enrolled (six boys and three girls; aged 10 days–3 years), one metabolic error, five excitotoxicity, one cytokine storm, and two hypoxia cases were found. The patients presented with unilateral convulsions, generalized convulsions, and convulsions following cardiopulmonary arrest, apnea, and nuchal rigidity. In all patients, a rapid check for RSV of nasal fluid was positive. The RSV genome (subgroup A) was detected in the CSF of five of the nine patients; two patients with hypoxic encephalopathy were negative for the RSV genome. The CSF interleukin (IL)-6 levels were high only in patients with the excitotoxicity and cytokine storm type of encephalopathy. NO x levels were high in all the subject cases. In the excitotoxicity type, NO x levels were significantly higher than those in the control and other groups. NO x level may become an important parameter for the diagnosis and classification of acute encephalopathy in RSV. Strategies to treat each type of encephalopathy, targeting cytokines and free radicals, should be established.
Literature
1.
go back to reference Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143:S142–9.PubMedCrossRef Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143:S142–9.PubMedCrossRef
2.
go back to reference Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32:307–10.PubMedCrossRef Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32:307–10.PubMedCrossRef
3.
go back to reference Ng YT, Cox C, Atkins J, Butler IJ, et al. Encephalopathy associated with respiratory syncytial virus bronchiolitis. J Child Neurol. 2001;16:105–8.PubMed Ng YT, Cox C, Atkins J, Butler IJ, et al. Encephalopathy associated with respiratory syncytial virus bronchiolitis. J Child Neurol. 2001;16:105–8.PubMed
4.
go back to reference Van Steensel-Moll HA, Van der Voort E, Bos AP, Rothbarth PH, Neijens HJ. Respiratory syncytial virus infections in children admitted to the intensive care unit. Pediatrie. 1998;44:583–8. Van Steensel-Moll HA, Van der Voort E, Bos AP, Rothbarth PH, Neijens HJ. Respiratory syncytial virus infections in children admitted to the intensive care unit. Pediatrie. 1998;44:583–8.
5.
go back to reference Inoue S, Nakazawa T, Kantake M, Kaneko K, Shimojima T. Early infantile patients of RS viral bronchiolitis with afebrile convulsions. Brain Dev 2003;35:347–49 (in Japanese). Inoue S, Nakazawa T, Kantake M, Kaneko K, Shimojima T. Early infantile patients of RS viral bronchiolitis with afebrile convulsions. Brain Dev 2003;35:347–49 (in Japanese).
6.
go back to reference Antonucci R, Antonucci R, Fanos V. Acute encephalopathy associated with respiratory syncytial virus infections in childhood. Minerva Pediatr. 2005;57:137–42.PubMed Antonucci R, Antonucci R, Fanos V. Acute encephalopathy associated with respiratory syncytial virus infections in childhood. Minerva Pediatr. 2005;57:137–42.PubMed
7.
go back to reference Bajanowski T, Bajanowski T, Rolf B, Jorch G, Brinkmann B. Detection of RNA viruses in sudden infant death (SID). Int J Legal Med. 2003;117:237–40.PubMedCrossRef Bajanowski T, Bajanowski T, Rolf B, Jorch G, Brinkmann B. Detection of RNA viruses in sudden infant death (SID). Int J Legal Med. 2003;117:237–40.PubMedCrossRef
8.
go back to reference Rambaud C. Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths. FEMS Immunol Med Microbiol. 1999;25:59–66.PubMedCrossRef Rambaud C. Microbiology in sudden infant death syndrome (SIDS) and other childhood deaths. FEMS Immunol Med Microbiol. 1999;25:59–66.PubMedCrossRef
9.
go back to reference Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115:45–56.PubMedCrossRef Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115:45–56.PubMedCrossRef
10.
go back to reference Yamanaka G, Kawashima H, Suganami Y, Watanabe C, Watanabe Y, Miyajima T, et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci. 2006;243(1-2):71–5.PubMedCrossRef Yamanaka G, Kawashima H, Suganami Y, Watanabe C, Watanabe Y, Miyajima T, et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci. 2006;243(1-2):71–5.PubMedCrossRef
11.
go back to reference Ichiyama T, Suenaga N, Kajimoto M, Tohyama J, Isumi H, Kubota M, et al. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev. 2008;30:47–52.PubMedCrossRef Ichiyama T, Suenaga N, Kajimoto M, Tohyama J, Isumi H, Kubota M, et al. Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev. 2008;30:47–52.PubMedCrossRef
12.
go back to reference Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J. 2004;23(11):1065–6.PubMedCrossRef Zlateva KT, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J. 2004;23(11):1065–6.PubMedCrossRef
13.
go back to reference Otake Y, Yamagata T, Morimoto Y, Imi M, Mori M, Aihara T, et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev. 2007;29:117–20.PubMedCrossRef Otake Y, Yamagata T, Morimoto Y, Imi M, Mori M, Aihara T, et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev. 2007;29:117–20.PubMedCrossRef
14.
go back to reference Kawashima H, Ioi H, Ushio M, Yamanaka G, Matsumoto S, Nakayama T. Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand J Infect Dis 2009;41(3):228–31. Kawashima H, Ioi H, Ushio M, Yamanaka G, Matsumoto S, Nakayama T. Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand J Infect Dis 2009;41(3):228–31.
15.
go back to reference Ichiyama T, Nishikawa M, Yoshitomi T, Hayashi T, Furukawa S. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures Comparison with acute encephalitis/encephalopathy. Neurology. 1998;50:407–11.PubMed Ichiyama T, Nishikawa M, Yoshitomi T, Hayashi T, Furukawa S. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures Comparison with acute encephalitis/encephalopathy. Neurology. 1998;50:407–11.PubMed
16.
go back to reference Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57:295–9.PubMed Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57:295–9.PubMed
17.
go back to reference Yamamoto H, Hayashi M. Multi-center survey of edaravone treatment in children. Brain Dev 2008;40:333–334 (in Japanese). Yamamoto H, Hayashi M. Multi-center survey of edaravone treatment in children. Brain Dev 2008;40:333–334 (in Japanese).
18.
go back to reference Ushio M, Yui I, Yoshida N, Fujino M, Yonekawa T, Ota Y, et al. Detection of respiratory syncytial virus genome by subgroups-A, B specific reverse transcription loop-mediated isothermal amplification (RT-LAMP). J Med Virol. 2007;77:121–7.CrossRef Ushio M, Yui I, Yoshida N, Fujino M, Yonekawa T, Ota Y, et al. Detection of respiratory syncytial virus genome by subgroups-A, B specific reverse transcription loop-mediated isothermal amplification (RT-LAMP). J Med Virol. 2007;77:121–7.CrossRef
19.
go back to reference Kornelisse RF, Hoekman K, Visser JJ, Hop WC, Huijmans JG, van der Straaten PJ, et al. The role of nitric oxide in bacterial meningitis in children. J Infect Dis. 1996;174:120–6.PubMedCrossRef Kornelisse RF, Hoekman K, Visser JJ, Hop WC, Huijmans JG, van der Straaten PJ, et al. The role of nitric oxide in bacterial meningitis in children. J Infect Dis. 1996;174:120–6.PubMedCrossRef
20.
go back to reference Yokota S, Imagawa T, Miyamae T, Ito S, Nakajima S, Nezu A, et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42:197–203.PubMedCrossRef Yokota S, Imagawa T, Miyamae T, Ito S, Nakajima S, Nezu A, et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42:197–203.PubMedCrossRef
21.
go back to reference Kawashima H, Watanabe Y, Ichiyama T, Mizuguchi M, Yamada N, Kashiwagi Y, et al. High concentration of serum nitrite/nitrate obtained from patients with influenza-associated encephalopathy. Pediatr Int. 2002;44:705–7.PubMedCrossRef Kawashima H, Watanabe Y, Ichiyama T, Mizuguchi M, Yamada N, Kashiwagi Y, et al. High concentration of serum nitrite/nitrate obtained from patients with influenza-associated encephalopathy. Pediatr Int. 2002;44:705–7.PubMedCrossRef
22.
go back to reference Kawashima H, Ioi H, Yamanaka G. Acute encephalopathy and respiratory syncytial virus. Pediatr J 2007;48:1951–57 (in Japanese). Kawashima H, Ioi H, Yamanaka G. Acute encephalopathy and respiratory syncytial virus. Pediatr J 2007;48:1951–57 (in Japanese).
23.
go back to reference Szabo FK, Lomenick JP. Syndrome of inappropriate antidiuretic hormone secretion in an infant with respiratory syncytial virus bronchiolitis. Clin Pediatr (Phila). 2008;47:840–2.CrossRef Szabo FK, Lomenick JP. Syndrome of inappropriate antidiuretic hormone secretion in an infant with respiratory syncytial virus bronchiolitis. Clin Pediatr (Phila). 2008;47:840–2.CrossRef
Metadata
Title
Classification of acute encephalopathy in respiratory syncytial virus infection
Authors
Shinichiro Morichi
Hisashi Kawashima
Hiroaki Ioi
Gaku Yamanaka
Yasuyo Kashiwagi
Akinori Hoshika
Tetsuo Nakayama
Yasuo Watanabe
Publication date
01-12-2011
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 6/2011
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0259-5

Other articles of this Issue 6/2011

Journal of Infection and Chemotherapy 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.